Capricor Therapeutics

CAPR • NASDAQ • Stock Fundamentals

Capricor Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Linda Marbán, with a market cap of $1.7B.

Market Cap$1.7B

Employees102.0

CEOLinda Marbán

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Capricor Therapeutics

Capricor Therapeutics (CAPR) has a market capitalization of $1.7B and trades on NASDAQ.

Capricor Therapeutics has approximately 102 employees.